As you may already know that Saudi Arabia has opened its doors to foreign tourists, and lift off the suspension of entry for tourist visa holders, starting from August 1, 2021.
It must be noted that tourists from 49 countries can now travel to Saudi Arabia for tourism purposes.
The country has been simplified for obtaining a multiple-entry electronic visa for a period of one year, allowing tourists to spend up to 90 days in the Kingdom.
The terms and conditions for obtaining a tourist visa and entering the Kingdom include full immunization with one of the approved vaccines in the Kingdom, in addition to a negative PCR test conducted within 72 hours from the time of departure and registration in the Muqeem portal.
Tourists From Below Countries Can Travel To Saudi Arabia
|China (Hong Kong, Macau)||Liechtenstein||Singapore|
|Czech Republic||Malaysia||South Korea|
|Germany||New Zealand||United States of America|
Tourists and visitors who belong to nationalities of 49 countries are eligible to apply for e-visa. The tourists can perform Umrah and experience diverse activities related to tourism across the Kingdom.
Requirement For Travel
Tourists to the Kingdom are also required to register their data related to vaccination doses on the new electronic portal https://muqeem.sa/#/vaccine-registration/home, the ministry said in a statement, adding that data is also recorded through the Tawakkalna application and is needed to be shown to enter public places.
To accommodate travelers, the Kingdom has upgraded the Tawakkalna application, allowing temporary visitors to register with their passport details.
The app is required for entry into both public and private entities as well as many public places in the Kingdom including shopping malls, cinemas, restaurants, and entertainment venues.
According to the statement, fully vaccinated are those who have received two doses of a vaccine that is approved in Saudi Arabia;
List of Vaccines Approved By Saudi Arabia
- Pfizer/BioNTech: Comirnaty
- Oxford/AstraZeneca: Vaxzevria
- Johnson & Johnson: Ad26.COV2.S
- Moderna: mRNA-1273
- Sinopharm: BBIBP-CorV
- Sinovac: CoronaVac